Findings reveal inflammasome activation and pyroptosis in neutrophils by metalloproteinase, suggesting targets for inflammatory response management.
Bothrops jararacussu venom contains snake venom metalloproteinases (SVMPs) that contribute to inflammation and tissue damage. BjussuMP-II, a PI-class SVMP, lacks hemorrhagic activity but retains proteolytic and immunomodulatory properties. Here, we uncover a previously unrecognized function of BjussuMP-II in triggering NLRP3 inflammasome activation in human neutrophils, leading to IL-1β release and pyroptosis. This discovery reveals a direct molecular link between SVMP activity and inflammasome-mediated inflammation, a fundamental mechanism with implications beyond snakebite pathology, and highlights inflammasomes as potential therapeutic targets to mitigate severe inflammatory responses in envenomed patients. Mechanistically, BjussuMP-II increased expression of NLRP3, ASC, CASPASE-1, NEK7, and HIF-1α, as well as IL-1β and Gasdermin D (GSDMD) cleavage, confirmed by immunoblotting and immunofluorescence. It promoted the release of IL-1β, LTB4, LDH, and dsDNA, consistent with pyroptosis, which was reduced by MCC950 or disulfiram. Studies in Gsdmd⁻/⁻ and HIF-1α-deficient neutrophils further demonstrated the requirement of these pathways for cytokine release. Collectively, these results indicate that BjussuMP-II modulates inflammasome-associated signaling pathways in neutrophils, contributing to the inflammatory responses triggered by snake venom metalloproteinases.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: